AMWL vs GDRX
AMWL: Amwell provides a comprehensive digital care platform that enables health systems and insurers to deliver virtual health services integrated into their existing clinical workflows. GDRX: GoodRx is a leading digital healthcare platform that provides price transparency and discount tools to help Americans save money on prescription medications and access healthcare services.
Side-by-side fundamentals
| Metric | AMWL | GDRX | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $11.66 | $2.93 | |
| Market cap as of 2026-07-23 | $195M | $992M | |
| P/E as of 2026-07-23 | n/a | 48.27 | |
| PEG as of 2026-07-23 | n/a | -39.73 | |
| Net margin as of 2026-07-23 | -37.0% | +2.6% | GDRX higher |
| Gross margin as of 2026-07-23 | +53.8% | +91.8% | GDRX higher |
| Operating margin as of 2026-07-23 | -37.2% | +9.9% | GDRX higher |
| ROE as of 2026-07-23 | -35.1% | +3.3% | GDRX higher |
| ROA as of 2026-07-23 | -25.1% | +1.4% | GDRX higher |
| Debt / equity as of 2026-07-23 | 0.00 | 0.78 | AMWL lower |
| Revenue growth (YoY) as of 2026-07-23 | -9.3% | -1.2% | GDRX higher |
| Revenue CAGR (3y) SEC XBRL | -3.5% | +1.3% | GDRX higher |
| Beta as of 2026-07-23 | 1.70 | 1.59 | |
| 1-year return as of 2026-07-22 close | +55.5% | -40.4% | AMWL higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.